Regeneron Chief Executive Dr. Leonard Schleifer has said to CNBC that the company will be provoding 300,000 doses of its Covid-19 antibody treatment for the United States by early January. According to Schleifer, the company will be able to supply 100,000 doses a month after that point. It was this past weekend that the Food … Continue reading “Regeneron CEO Says Company Will Provide 300,000 Doses of Covid Treatment for US by January”
Tag: regeneron
Hot Stocks
Sanofi to Sell Stake in Regeneron Pharmaceuticals for Roughly $13B
French multinational pharmaceutical company Sanofi is selling a stake in Regeneron Pharmaceuticals Inc. valued at…
May 26, 2020